Tori Rodriguez, MA, LPC, AHC

Sleep disturbances may affect 40% to 90% of patients with PD, and a 2020 study found that about half of patients with PD had multiple sleep disorders.

The bidirectional relationship between migraine and sleep disorders are examined in this article.

The microbiota-gut-brain axis represents a bidirectional communication pathway through which the gut microbiota may influence the CNS.

In this review, study authors discuss and summarize the current evidence for the evaluation and management of the most prevalent and well-described conditions in SCI, including impact of SCI on sleep and daytime function.

The clinical approach to management of Cushing disease is often complex and education on a clear approach is paramount.

Studies show increased rate of all types of dementia in patients with AF, with new data finding treatment of AF lowers risk for cognitive dysfunction.

Delirium is highly prevalent in critical care, especially among elderly patients and individuals with dementia. Although rates vary widely across studies, findings suggest delirium affects more than 15% of hospitalized patients. For additional discussion regarding this topic, Neurology Advisor interviewed Leopoldo Pozuelo, MD, MBA, FACP, FACLP, clinical vice chair of psychiatry and psychology at the Cleveland Clinic in Ohio.

Researchers found data that showed, after consultation with an expert, optimal prevention of migraine headaches for patients who present in the emergency department includes both antiseizure medications, specifically, divalproex sodium, sodium valproate, or topiramate, and β-blockers, namely, metoprolol, propranolol, and timolol. In addition, triptans are suggested, as well as antidepressants, amitriptyline, and venlafaxine.

In an interview with Neurology Advisor, Robert Cowan, MD, FAAN explains how thunderclap headache may be the only early warning sign of vascular changes or brain injury.

The integration of technology into medicine has expanded into various uses in patients with Parkinson disease.

Researchers found that lower levels of estrogen during menstruation cause women to be more vulnerable to migraines than men.